1,2-distearoylphosphatidylethanolamine and phosphotyrosine

1,2-distearoylphosphatidylethanolamine has been researched along with phosphotyrosine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, F; Chen, H; Ding, N; Du, S; Liu, B; Meng, F; Qian, H; Sha, H; Su, S; Wei, J; Yang, J; Zhang, L; Zhou, S; Zou, Z	1

Other Studies

1 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and phosphotyrosine

Article	Year
iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer. Nature communications, 2019, 03-22, Volume: 10, Issue:1 Topics: Animals; Antigens, CD; Cadherins; Cell Line, Tumor; Gene Knockout Techniques; Human Umbilical Vein Endothelial Cells; Humans; Immunotherapy; Lymphocytes; Male; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Peritoneal Neoplasms; Phosphatidylethanolamines; Phosphorylation; Phosphotyrosine; Polyethylene Glycols; Programmed Cell Death 1 Receptor; Spheroids, Cellular; Stomach Neoplasms; Subcutaneous Tissue	2019

Article

Year

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer.

Nature communications, 2019, 03-22, Volume: 10, Issue:1

Topics: Animals; Antigens, CD; Cadherins; Cell Line, Tumor; Gene Knockout Techniques; Human Umbilical Vein Endothelial Cells; Humans; Immunotherapy; Lymphocytes; Male; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Peritoneal Neoplasms; Phosphatidylethanolamines; Phosphorylation; Phosphotyrosine; Polyethylene Glycols; Programmed Cell Death 1 Receptor; Spheroids, Cellular; Stomach Neoplasms; Subcutaneous Tissue

2019